SG47958A1 - Aminoquinoline derivatives - Google Patents
Aminoquinoline derivativesInfo
- Publication number
- SG47958A1 SG47958A1 SG1996005663A SG1996005663A SG47958A1 SG 47958 A1 SG47958 A1 SG 47958A1 SG 1996005663 A SG1996005663 A SG 1996005663A SG 1996005663 A SG1996005663 A SG 1996005663A SG 47958 A1 SG47958 A1 SG 47958A1
- Authority
- SG
- Singapore
- Prior art keywords
- alkyl
- hydrogen
- tetramethylene
- tri
- symbols
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH325593 | 1993-10-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG47958A1 true SG47958A1 (en) | 1998-04-17 |
Family
ID=4252022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996005663A SG47958A1 (en) | 1993-10-28 | 1994-10-15 | Aminoquinoline derivatives |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5596002A (fr) |
| EP (1) | EP0656353B1 (fr) |
| JP (1) | JP2922122B2 (fr) |
| CN (2) | CN1054124C (fr) |
| AT (1) | ATE166868T1 (fr) |
| AU (1) | AU696109B2 (fr) |
| CA (1) | CA2133620A1 (fr) |
| DE (1) | DE59406126D1 (fr) |
| DK (1) | DK0656353T3 (fr) |
| ES (1) | ES2118294T3 (fr) |
| IL (1) | IL111355A (fr) |
| MY (1) | MY113383A (fr) |
| NZ (1) | NZ264763A (fr) |
| SG (1) | SG47958A1 (fr) |
| ZA (1) | ZA948305B (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996040138A1 (fr) * | 1995-06-07 | 1996-12-19 | The Administrators Of The Tulane Educational Fund | Analogues de la chloroquine et procedes de prevention et de traitement de maladie plasmodique |
| US6025359A (en) * | 1996-06-17 | 2000-02-15 | Eli Lilly And Company | Drug resistance and multidrug resistance modulators |
| US5776939A (en) * | 1997-06-12 | 1998-07-07 | Eli Lilly And Company | Drug resistance and multidrug resistance modulators |
| GB9904419D0 (en) * | 1999-02-25 | 1999-04-21 | Univ Liverpool | 4-aminoquinolines |
| WO2001003649A2 (fr) | 1999-07-13 | 2001-01-18 | Alpha Research Group, Llc | Traitement de la maladie de parkinson et compositions a cet effet |
| US20040229908A1 (en) * | 1999-07-13 | 2004-11-18 | Jodi Nelson | Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias |
| US7217722B2 (en) * | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| GB0012874D0 (en) * | 2000-05-27 | 2000-07-19 | Ufc Limited | 4-Aminoquinolines |
| AU2002304733A1 (en) * | 2001-04-17 | 2002-10-28 | Actelion Pharmaceuticals Ltd. | Amino-aza-cyclohexanes for the treatment of malaria |
| MXPA04007502A (es) * | 2002-02-04 | 2004-11-10 | Hoffmann La Roche | Derivados de quinolina como antagonistas de neuropeptido y (npy). |
| US20060014786A1 (en) * | 2002-05-17 | 2006-01-19 | Rajeev Raut | Opthalmic pharmaceutical compositions and methods for treating ocular inflammation |
| US7084157B2 (en) * | 2002-05-17 | 2006-08-01 | Rajeev Raut | Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation |
| US7108992B2 (en) * | 2002-11-27 | 2006-09-19 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
| US6916627B2 (en) * | 2002-11-27 | 2005-07-12 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
| EP1846401B1 (fr) * | 2005-02-04 | 2008-06-18 | CTG Pharma S.r.l. | Nouveaux dérivés de 4-aminoquinoléine comme composés antimalaria |
| US7968539B2 (en) | 2005-02-17 | 2011-06-28 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Portland State University | Quinoline derivatives and uses thereof |
| WO2007059372A2 (fr) * | 2005-11-09 | 2007-05-24 | St. Jude Children's Research Hospital | Utilisation de chloroquine en vue de traiter un syndrome metabolique |
| FR2902100A1 (fr) * | 2006-06-13 | 2007-12-14 | Sanofi Aventis Sa | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique |
| US20080189982A1 (en) * | 2007-02-09 | 2008-08-14 | Krafsur Andrew B | Shoe spring sole insert |
| US8481543B2 (en) | 2008-11-18 | 2013-07-09 | Oregon Health & Science University | Compounds for treating parasitic disease |
| WO2022112596A1 (fr) | 2020-11-30 | 2022-06-02 | Cellectis Sa | Utilisation de composés d'aminoquinoline pour une intégration de gènes plus élevée |
| CN115160296B (zh) * | 2022-08-08 | 2024-05-28 | 西安市第五医院 | 一种n-取代喹啉-4-胺类化合物及其制备、药物组合物和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2594419A (en) * | 1949-09-30 | 1952-04-29 | Geschickter Fund Med Res | Di-salicylate of 7-chloro-4-(4'-diethylamino-1'-methylbutylamino) quinoline |
| NL265777A (fr) * | 1960-06-09 | |||
| US3346579A (en) * | 1966-04-25 | 1967-10-10 | Squibb & Sons Inc | Iodine chloride complexes of quinoline and acridine compounds |
| FR2498187A1 (fr) * | 1981-01-16 | 1982-07-23 | Rhone Poulenc Sante | Procede de preparation d'amino-4 chloro-7 quinoleines |
| FR2612778B1 (fr) * | 1987-03-24 | 1991-10-18 | Ire Cell Targ Sa | Nouveaux derives d'aminoquinoleine antimalarique, procede de preparation et composition pharmaceutique en contenant |
| DE69230397T2 (de) * | 1991-10-01 | 2000-06-08 | Dainippon Ink And Chemicals, Inc. | Fluorbenzonitrile und sie enthaltende flüssigkristalline gemische |
| US5510356A (en) * | 1991-10-03 | 1996-04-23 | University Of Nebraska Board Of Regents | Bisquinolines and processes for their production and use to treat malaria |
-
1994
- 1994-10-04 CA CA002133620A patent/CA2133620A1/fr not_active Abandoned
- 1994-10-15 DK DK94116281T patent/DK0656353T3/da active
- 1994-10-15 EP EP94116281A patent/EP0656353B1/fr not_active Expired - Lifetime
- 1994-10-15 SG SG1996005663A patent/SG47958A1/en unknown
- 1994-10-15 AT AT94116281T patent/ATE166868T1/de not_active IP Right Cessation
- 1994-10-15 ES ES94116281T patent/ES2118294T3/es not_active Expired - Lifetime
- 1994-10-15 DE DE59406126T patent/DE59406126D1/de not_active Expired - Fee Related
- 1994-10-21 IL IL11135594A patent/IL111355A/en not_active IP Right Cessation
- 1994-10-21 ZA ZA948305A patent/ZA948305B/xx unknown
- 1994-10-24 AU AU77419/94A patent/AU696109B2/en not_active Ceased
- 1994-10-25 NZ NZ264763A patent/NZ264763A/en unknown
- 1994-10-26 JP JP6262657A patent/JP2922122B2/ja not_active Expired - Fee Related
- 1994-10-26 US US08/329,596 patent/US5596002A/en not_active Expired - Fee Related
- 1994-10-26 MY MYPI94002847A patent/MY113383A/en unknown
- 1994-10-27 CN CN94117661A patent/CN1054124C/zh not_active Expired - Fee Related
-
1998
- 1998-06-05 CN CN98109580A patent/CN1130345C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1106389A (zh) | 1995-08-09 |
| IL111355A (en) | 2001-11-25 |
| AU696109B2 (en) | 1998-09-03 |
| DE59406126D1 (de) | 1998-07-09 |
| CN1054124C (zh) | 2000-07-05 |
| EP0656353B1 (fr) | 1998-06-03 |
| ZA948305B (en) | 1995-05-02 |
| AU7741994A (en) | 1995-05-18 |
| CN1245168A (zh) | 2000-02-23 |
| CN1130345C (zh) | 2003-12-10 |
| JPH07188174A (ja) | 1995-07-25 |
| MY113383A (en) | 2002-02-28 |
| DK0656353T3 (da) | 1999-02-01 |
| US5596002A (en) | 1997-01-21 |
| JP2922122B2 (ja) | 1999-07-19 |
| ES2118294T3 (es) | 1998-09-16 |
| EP0656353A1 (fr) | 1995-06-07 |
| IL111355A0 (en) | 1994-12-29 |
| NZ264763A (en) | 1997-10-24 |
| ATE166868T1 (de) | 1998-06-15 |
| CA2133620A1 (fr) | 1995-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG47958A1 (en) | Aminoquinoline derivatives | |
| NO994582D0 (no) | Fremgangsmaate for fremstilling av piperidinderivater | |
| ZA893104B (en) | Novel benzopyrido piperidine,piperidylidene and piperazine compounds,compositions,methods of manufacture and methods of use | |
| ATE147071T1 (de) | 1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung | |
| NZ221543A (en) | 4-aminoquinoline derivatives and pharmaceutical compositions containing such | |
| AU667920B2 (en) | New piperidine derivatives of benzimidazole | |
| ATE180780T1 (de) | 2-(piperidin-4-yl, pyridin-4-yl und tetrahydropyridin-4-yl)-benzofuran-7-carbamat derivate, ihre herstellung und verwendung als acetylcholinesterase inhibitoren | |
| HU9601568D0 (en) | Cyclic amide derivatives as neurokinin antagonists | |
| NZ214156A (en) | Quindone derivatives and pharmaceutical compositions | |
| DE69227088D1 (de) | Verwendung von 1-(aminoalkyl)-3-Quinoxalin-2-on Derivaten zur Herstellung von neuroprotektiven Mitteln | |
| DE69428142D1 (de) | Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung | |
| FI860199A (fi) | Tricykliska foereningar, dessa innehaollande kompositioner, foerfarande foer deras framstaellning och vaordfoerfarande medelst anvaendning av dessa. | |
| DE69429185D1 (de) | Imidazolidinon-derivate, deren säure-additionssalze und mittel gegen senile demenz | |
| AU646611B2 (en) | 4-{4- or 6-(trifluoromethyl-2-pyridinyl)}-1-piperazinyl- alkyl substituted lactams | |
| DE3067580D1 (en) | Substituted 4-amino-2,6-diaryl-tetrahydrothiopyranes, their acid-addition salts, processes for their preparation and pharmaceutical compositions | |
| MY104630A (en) | 4(1h) ouinoline derivatives | |
| ZA908309B (en) | Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives |